• No results found

Durability test with fuel starvation using a Pt/CNF catalyst in PEMFC

N/A
N/A
Protected

Academic year: 2020

Share "Durability test with fuel starvation using a Pt/CNF catalyst in PEMFC"

Copied!
8
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Table 2 summarizes the physical properties of the Pt/CNF. The weight percentages of the Pt catalyst to theweight of the synthesized Pt/CNF and the commercialPt/C were approximately 47.5 wt.% and 50.7 wt.%,respectively, based on the TGA analysis
Figure 1 Pore size distribution (BJH adsorption cumulative pore volume) of synthesized Pt/CNF and commercial Pt/C catalysts.
Figure 3 TEM images of the (a) commercial Pt/C and (b) Pt/CNF catalysts.
Figure 4 Hydropilicity of commercial Pt/C and Pt/CNF catalysts (a) before and (b) after 2 h.
+3

References

Related documents

Similarly, beef muscles at a greater depth in the carcass (e.g. deep in the butt) which are at a higher temperature for longer period are more likely to exhibit the P S E

Grazed elk ranges differ from grazed caffle ranges. Composifion changes were defected for 18 planf species occurring on bofh fypes of range. In northwestern

The averages, standard deviations and Hurst exponents for the Rainfall time series of all the 19 rain gauge stations are tabulated in Table 1.For all the 19 stations, 384 values

Mass balance Case 1,15 bara liquefaction pressure, Stream Numbering from Figure 1. Mass balance Case 2,15 bara liquefaction pressure, Stream Numbering from

A comparative study of cone-beam computed tomography and conventional panoramic radiography in assessing the topographic relationship between the mandibular canal

Keywords: nucleus structure; parameters of external shells; correlation of radii of nuclei and atoms; periodic law.. Mendeleev not only substantiated the dependence of the

36 The book most historians of anthropology and racial theory have read is The Natural History of Man: Comprising Inquiries into the Modifying Influence of Physical and Moral

Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive meta- static